BACKGROUND: People with depression commonly use the Internet to access antidepressant information, but the quality of this information is highly variable. The objective of this study was to assess how and why people use the Internet to access antidepressant information, and the self-reported impact of information obtained online. METHODS: Six focus groups were conducted with a cross-section of Internet users (n=29) with depression. Focus group transcripts were thematically content analyzed using a constant comparison approach. RESULTS: Reasons cited for seeking online information included to obtain a second opinion, to verify information provided in the Package Information Leaflet, to prepare to visit to a physician, and to learn about peer experiences. The Internet was used to complement rather than replace information provided by health professionals. The self-reported impacts of utilizing online drug information included increased autonomy, improved knowledge, being reassured, deciding to change a dose, to discontinue a drug and to suggest a new drug to a physician. LIMITATIONS: Additional quantitative research and a random sampling technique would be required to obtain generalizable results and to assess the relative importance of the various reasons cited by the focus group participants. CONCLUSIONS: The Internet was perceived as an important source of additional drug information, particularly when fear of stigmatization or depression related symptoms limited information seeking from other sources. Health professionals should design online services and direct their clients to accurate and reliable sources of online drug information.
BACKGROUND:People with depression commonly use the Internet to access antidepressant information, but the quality of this information is highly variable. The objective of this study was to assess how and why people use the Internet to access antidepressant information, and the self-reported impact of information obtained online. METHODS: Six focus groups were conducted with a cross-section of Internet users (n=29) with depression. Focus group transcripts were thematically content analyzed using a constant comparison approach. RESULTS: Reasons cited for seeking online information included to obtain a second opinion, to verify information provided in the Package Information Leaflet, to prepare to visit to a physician, and to learn about peer experiences. The Internet was used to complement rather than replace information provided by health professionals. The self-reported impacts of utilizing online drug information included increased autonomy, improved knowledge, being reassured, deciding to change a dose, to discontinue a drug and to suggest a new drug to a physician. LIMITATIONS: Additional quantitative research and a random sampling technique would be required to obtain generalizable results and to assess the relative importance of the various reasons cited by the focus group participants. CONCLUSIONS: The Internet was perceived as an important source of additional drug information, particularly when fear of stigmatization or depression related symptoms limited information seeking from other sources. Health professionals should design online services and direct their clients to accurate and reliable sources of online drug information.
Authors: Ulla Närhi; Marika Pohjanoksa-Mäntylä; Anna Karjalainen; Johanna K Saari; Hannes Wahlroos; Marja S Airaksinen; Simon J Bell Journal: Pharm World Sci Date: 2008-09-13
Authors: S Elina Aaltonen; Niina P Laine; Daisy Volmer; Manjiri S Gharat; Ruta Muceniece; Anna Vitola; Veerle Foulon; Franciska A Desplenter; Marja S Airaksinen; Timothy F Chen; J Simon Bell Journal: Pharm Pract (Granada) Date: 2010-03-15
Authors: Jörn Conell; Rita Bauer; Tasha Glenn; Martin Alda; Raffaella Ardau; Bernhard T Baune; Michael Berk; Yuly Bersudsky; Amy Bilderbeck; Alberto Bocchetta; Letizia Bossini; Angela Marianne Paredes Castro; Eric Yat Wo Cheung; Caterina Chillotti; Sabine Choppin; Maria Del Zompo; Rodrigo Dias; Seetal Dodd; Anne Duffy; Bruno Etain; Andrea Fagiolini; Julie Garnham; John Geddes; Jonas Gildebro; Ana Gonzalez-Pinto; Guy M Goodwin; Paul Grof; Hirohiko Harima; Stefanie Hassel; Chantal Henry; Diego Hidalgo-Mazzei; Vaisnvy Kapur; Girish Kunigiri; Beny Lafer; Chun Lam; Erik Roj Larsen; Ute Lewitzka; Rasmus Licht; Anne Hvenegaard Lund; Blazej Misiak; Patryk Piotrowski; Scott Monteith; Rodrigo Munoz; Takako Nakanotani; René E Nielsen; Claire O'Donovan; Yasushi Okamura; Yamima Osher; Andreas Reif; Philipp Ritter; Janusz K Rybakowski; Kemal Sagduyu; Brett Sawchuk; Elon Schwartz; Ângela Miranda Scippa; Claire Slaney; Ahmad Hatim Sulaiman; Kirsi Suominen; Aleksandra Suwalska; Peter Tam; Yoshitaka Tatebayashi; Leonardo Tondo; Eduard Vieta; Maj Vinberg; Biju Viswanath; Julia Volkert; Mark Zetin; Iñaki Zorrilla; Peter C Whybrow; Michael Bauer Journal: Int J Bipolar Disord Date: 2016-08-24
Authors: Frederick H F Chan; Xiaowen Lin; Konstadina Griva; Mythily Subramaniam; Ivan Ćelić; Lorainne Tudor Car Journal: BMC Psychiatry Date: 2022-07-27 Impact factor: 4.144